guest ::
| Home > Publications Database > Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19. > print |
| Home > Publications Database > Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19. > print |
| 001 | 273942 | ||
| 005 | 20250120102328.0 | ||
| 024 | 7 | _ | |a 10.1016/j.chom.2024.11.007 |2 doi |
| 024 | 7 | _ | |a pmid:39615487 |2 pmid |
| 024 | 7 | _ | |a 1931-3128 |2 ISSN |
| 024 | 7 | _ | |a 1934-6069 |2 ISSN |
| 024 | 7 | _ | |a altmetric:171267237 |2 altmetric |
| 037 | _ | _ | |a DZNE-2024-01416 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Rong, Zhouyi |b 0 |
| 245 | _ | _ | |a Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19. |
| 260 | _ | _ | |a Amsterdam [u.a.] |c 2024 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1734101553_30057 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a SARS-CoV-2 infection is associated with long-lasting neurological symptoms, although the underlying mechanisms remain unclear. Using optical clearing and imaging, we observed the accumulation of SARS-CoV-2 spike protein in the skull-meninges-brain axis of human COVID-19 patients, persisting long after viral clearance. Further, biomarkers of neurodegeneration were elevated in the cerebrospinal fluid from long COVID patients, and proteomic analysis of human skull, meninges, and brain samples revealed dysregulated inflammatory pathways and neurodegeneration-associated changes. Similar distribution patterns of the spike protein were observed in SARS-CoV-2-infected mice. Injection of spike protein alone was sufficient to induce neuroinflammation, proteome changes in the skull-meninges-brain axis, anxiety-like behavior, and exacerbated outcomes in mouse models of stroke and traumatic brain injury. Vaccination reduced but did not eliminate spike protein accumulation after infection in mice. Our findings suggest persistent spike protein at the brain borders may contribute to lasting neurological sequelae of COVID-19. |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a SARS-CoV-2 |2 Other |
| 650 | _ | 7 | |a brain |2 Other |
| 650 | _ | 7 | |a long COVID |2 Other |
| 650 | _ | 7 | |a mRNA vaccine |2 Other |
| 650 | _ | 7 | |a meninges |2 Other |
| 650 | _ | 7 | |a neurodegeneration |2 Other |
| 650 | _ | 7 | |a neuroinflammation |2 Other |
| 650 | _ | 7 | |a skull |2 Other |
| 650 | _ | 7 | |a spike protein |2 Other |
| 650 | _ | 7 | |a tissue clearing |2 Other |
| 650 | _ | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM Chemicals |
| 650 | _ | 7 | |a spike protein, SARS-CoV-2 |2 NLM Chemicals |
| 650 | _ | 2 | |a COVID-19: metabolism |2 MeSH |
| 650 | _ | 2 | |a COVID-19: virology |2 MeSH |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Spike Glycoprotein, Coronavirus: metabolism |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a SARS-CoV-2 |2 MeSH |
| 650 | _ | 2 | |a Brain: virology |2 MeSH |
| 650 | _ | 2 | |a Brain: metabolism |2 MeSH |
| 650 | _ | 2 | |a Disease Models, Animal |2 MeSH |
| 650 | _ | 2 | |a Meninges: virology |2 MeSH |
| 650 | _ | 2 | |a Meninges: metabolism |2 MeSH |
| 650 | _ | 2 | |a Skull: virology |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Proteomics |2 MeSH |
| 650 | _ | 2 | |a Stroke: metabolism |2 MeSH |
| 650 | _ | 2 | |a Stroke: virology |2 MeSH |
| 650 | _ | 2 | |a Neuroinflammatory Diseases: metabolism |2 MeSH |
| 650 | _ | 2 | |a Neuroinflammatory Diseases: virology |2 MeSH |
| 650 | _ | 2 | |a Mice, Inbred C57BL |2 MeSH |
| 650 | _ | 2 | |a Brain Injuries, Traumatic: metabolism |2 MeSH |
| 650 | _ | 2 | |a Brain Injuries, Traumatic: virology |2 MeSH |
| 700 | 1 | _ | |a Mai, Hongcheng |b 1 |
| 700 | 1 | _ | |a Ebert, Gregor |b 2 |
| 700 | 1 | _ | |a Kapoor, Saketh |b 3 |
| 700 | 1 | _ | |a Puelles, Victor G |b 4 |
| 700 | 1 | _ | |a Czogalla, Jan |b 5 |
| 700 | 1 | _ | |a Hu, Senbin |b 6 |
| 700 | 1 | _ | |a Su, Jinpeng |b 7 |
| 700 | 1 | _ | |a Prtvar, Danilo |0 P:(DE-2719)9002550 |b 8 |u dzne |
| 700 | 1 | _ | |a Singh, Inderjeet |b 9 |
| 700 | 1 | _ | |a Schädler, Julia |b 10 |
| 700 | 1 | _ | |a Delbridge, Claire |b 11 |
| 700 | 1 | _ | |a Steinke, Hanno |b 12 |
| 700 | 1 | _ | |a Frenzel, Hannah |b 13 |
| 700 | 1 | _ | |a Schmidt, Katja |b 14 |
| 700 | 1 | _ | |a Braun, Christian |b 15 |
| 700 | 1 | _ | |a Bruch, Gina |b 16 |
| 700 | 1 | _ | |a Ruf, Viktoria |b 17 |
| 700 | 1 | _ | |a Ali, Mayar |b 18 |
| 700 | 1 | _ | |a Sühs, Kurt-Wolfram |b 19 |
| 700 | 1 | _ | |a Nemati, Mojtaba |0 P:(DE-2719)9002938 |b 20 |u dzne |
| 700 | 1 | _ | |a Hopfner, Franziska |0 P:(DE-2719)9003372 |b 21 |u dzne |
| 700 | 1 | _ | |a Ulukaya, Selin |b 22 |
| 700 | 1 | _ | |a Jeridi, Denise |b 23 |
| 700 | 1 | _ | |a Mistretta, Daniele |b 24 |
| 700 | 1 | _ | |a Caliskan, Özüm Sehnaz |b 25 |
| 700 | 1 | _ | |a Wettengel, Jochen Martin |b 26 |
| 700 | 1 | _ | |a Cherif, Fatma |0 P:(DE-2719)9003325 |b 27 |u dzne |
| 700 | 1 | _ | |a Kolabas, Zeynep Ilgin |b 28 |
| 700 | 1 | _ | |a Molbay, Müge |b 29 |
| 700 | 1 | _ | |a Horvath, Izabela |b 30 |
| 700 | 1 | _ | |a Zhao, Shan |b 31 |
| 700 | 1 | _ | |a Krahmer, Natalie |b 32 |
| 700 | 1 | _ | |a Yildirim, Ali Önder |b 33 |
| 700 | 1 | _ | |a Ussar, Siegfried |b 34 |
| 700 | 1 | _ | |a Herms, Jochen |0 P:(DE-2719)2810441 |b 35 |u dzne |
| 700 | 1 | _ | |a Huber, Tobias B |b 36 |
| 700 | 1 | _ | |a Tahirovic, Sabina |0 P:(DE-2719)2442036 |b 37 |u dzne |
| 700 | 1 | _ | |a Schwarzmaier, Susanne M |b 38 |
| 700 | 1 | _ | |a Plesnila, Nikolaus |b 39 |
| 700 | 1 | _ | |a Höglinger, Günter |0 P:(DE-2719)2811373 |b 40 |u dzne |
| 700 | 1 | _ | |a Ondruschka, Benjamin |b 41 |
| 700 | 1 | _ | |a Bechmann, Ingo |b 42 |
| 700 | 1 | _ | |a Protzer, Ulrike |b 43 |
| 700 | 1 | _ | |a Elsner, Markus |b 44 |
| 700 | 1 | _ | |a Bhatia, Harsharan Singh |b 45 |
| 700 | 1 | _ | |a Hellal, Farida |b 46 |
| 700 | 1 | _ | |a Ertürk, Ali |b 47 |
| 773 | _ | _ | |a 10.1016/j.chom.2024.11.007 |g Vol. 32, no. 12, p. 2112 - 2130.e10 |0 PERI:(DE-600)2276339-9 |n 12 |p 2112 - 2130.e10 |t Cell host and microbe |v 32 |y 2024 |x 1931-3128 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/273942/files/DZNE-2024-01416.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/273942/files/DZNE-2024-01416.pdf?subformat=pdfa |
| 909 | C | O | |o oai:pub.dzne.de:273942 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)9002550 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 20 |6 P:(DE-2719)9002938 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 21 |6 P:(DE-2719)9003372 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 27 |6 P:(DE-2719)9003325 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 35 |6 P:(DE-2719)2810441 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 37 |6 P:(DE-2719)2442036 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 40 |6 P:(DE-2719)2811373 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 1 |
| 914 | 1 | _ | |y 2024 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-25 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0 |0 LIC:(DE-HGF)CCBYNCND4 |2 HGFVOC |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL HOST MICROBE : 2022 |d 2023-10-25 |
| 915 | _ | _ | |a IF >= 30 |0 StatID:(DE-HGF)9930 |2 StatID |b CELL HOST MICROBE : 2022 |d 2023-10-25 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-25 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-25 |
| 920 | 1 | _ | |0 I:(DE-2719)1140003 |k AG Tahirovic |l Juvenile Neurodegeneration |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1111015 |k Clinical Research (Munich) |l Clinical Research (Munich) |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1140003 |
| 980 | _ | _ | |a I:(DE-2719)1111015 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|